Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Safe Supply Announces Strategic Expansion into AI-Powered Healthcare Solutions (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Indigenous Bloom Hemp Corp VRTHF

Cannabis
Indigenous Bloom Hemp Corporation is a Canada-based company, which produce and sell hemp extracts. The Company operates a large scale industrial hemp farm in southern Manitoba on approximately 200 acres of zoned farmland. The primary business of the Company is the sale of hemp biomass and flower (Hemp), Phyto cannabinoid rich (PCR) extracts derived from hemp biomass (Hemp Extracts). The Company... see more

Recent & Breaking News (GREY:VRTHF)

Health Canada's Improved Processing of ACMPR Applications and the Application Status of Veritas' Subsidiary,Sechelt Organic Marijuana Corp.

TheNewsWire June 6, 2017

Veritas Pharma Announces The Successful Expansion Of Cannevert Therapeutic's Anti-Emesis Research

TheNewsWire May 30, 2017

Veritas Pharma Appoints David Greenway to its Board of Directors

TheNewsWire May 17, 2017

Cannevert Presses on to its Goal of Clinical Trials

TheNewsWire May 8, 2017

Veritas Pharma Inc Closes On Its Acquisition Of Cannevert Therapeutics Ltd

TheNewsWire April 21, 2017

Veritas to Present at the Planet Microcap Showcase 2017 in Las Vegas; to Attend the Canadian Cannabis Business Conference In Toronto; and Supports Proposed Cannabis Legislation

TheNewsWire April 19, 2017

CDN Cannabis Expands Further into U.S. Market

Stockhouse Editorial March 15, 2017

Veritas Pharma Announces an Agreement for a Research and Development Application In Washington State

TheNewsWire March 14, 2017

Status of Health Canada Dealer's Licence Application to Produce, Gather or Cultivate cannabis for Scientific Purposes

TheNewsWire March 13, 2017

Veritas Provides An Update On Cannevert

TheNewsWire March 7, 2017

Veritas Provides Update ACMPR and Cannabis Cultivation Facility and Production Methodology

TheNewsWire March 5, 2017

Veritas Pharma Issues Incentive Stock Options

TheNewsWire March 3, 2017

Veritas Pharma Receives Latest Research Report from Cannavert Therapeutics

TheNewsWire February 23, 2017

Health Canada Final Review Notification Received For ACMPR Application

TheNewsWire February 20, 2017

Cannevert Scientist Accepted to Attend Bedrocan’s Masterclass on Medicinal Cannabis in Leiden, The Netherlands (March 2017)

TheNewsWire February 6, 2017

Veritas-Cannevert Commences Preparation of First Clinical Trials of Cannabis Targeting Pain

TheNewsWire January 31, 2017

Veritas Pharma Places Final Payment in Trust for the Acquisition of Cannevert Therapeutics

Newsfile January 25, 2017

Medical marijuana company announces installment payment

Stockhouse Editorial January 24, 2017

Veritas Pharma Advances Fifth of Six Equal Payments to Cannevert Therapeutics Ltd.

Newsfile January 23, 2017

Veritas Pharma Appoints Linda Sampson, President Of Marapharm Pharma (CSE: “MDM”) To The Board Of Directors Of Veritas

TheNewsWire January 11, 2017